Sihuan Pharma and Partners Pay $67 Million for Nanjing Hospital

Sihuan Pharma, its Chairman and a Morgan Stanley unit agreed to purchase a 69% stake in a Nanjing Jiangbei People’s Hospital for $66.8 million. The acquisition will be made through a Joint Venture, Renfang Medical Holdings Ltd., which was formed by the three partners. Earlier last month, Renfang paid $133.5 million for a stake in another hospital, located in Huaiyin, Jiangsu Province. More details.... Stock Symbol: (HK: 0460) Share this with colleagues: // //